Insider Buying Signals Amid a Sea of Sales
The latest Form 4 filing from owner Kunkel Joachim shows a modest purchase of 633 shares on October 5, 2026, bringing his total holdings to 75,328. The acquisition was executed through a fully vested restricted‑stock grant tied to the average trading price of $22.69, effectively a “buy” at the current market level of $24.13. While the trade itself is small relative to the 10‑b‑5‑1 sales recorded by other executives, it occurs against a backdrop of heightened social‑media buzz (≈392 %) and a near‑flat price change (0.01 %). For investors, Joachim’s action can be interpreted as a confidence signal that the company’s valuation remains attractive even as other insiders reduce their exposure.
What This Means for Investors
Arteris’ stock has already climbed 78.9 % year‑to‑date, with a 52‑week high of $50.26 and a low of $12.06, reflecting the sector’s strong demand for network‑on‑chip IP. The company’s negative P/E of –25.3 suggests earnings are below market expectations, yet its robust growth trajectory (6.21 % monthly and 3.74 % weekly) indicates that the market is pricing in future profitability. Joachim’s purchase—though small—adds a layer of insider endorsement. It may help temper the perception that the company is in a sell‑off phase, particularly given the aggressive divestitures by CEO Janac K. Charles and COO Laurent Moll earlier in October. For portfolio managers, this trade could be a cue to reassess risk‑to‑return dynamics in a company that is still building its product pipeline and expanding into automotive and mobile‑processor markets.
Profile of Kunkel Joachim
Kunkel’s trading history over the past 12 months shows a consistent pattern of accumulating shares, with purchases ranging from 365 shares in July 2026 to a substantial 20,839 shares in June 2025. The most notable spike was the 20,839‑share acquisition in June 2025, which increased his holdings to 64,595. Over time, his ownership has grown from 43,756 shares in April 2025 to 75,328 shares today—a 72 % increase. These purchases are all made at zero price, reflecting internal restricted‑stock or incentive‑plan grants rather than market trades. Joachim’s behavior suggests a long‑term commitment to Arteris, favoring gradual accumulation through vesting events rather than opportunistic buying.
Investor Takeaway
The combination of a steady insider buying trend, a high social‑media buzz, and a robust upward trajectory in price supports a bullish view for Arteris, albeit tempered by its negative earnings multiple. Investors should watch for continued insider purchases as a barometer of confidence, particularly when other executives are offloading shares. In a rapidly evolving semiconductor landscape, Joachim’s disciplined accumulation may signal that the company’s IP portfolio is positioned to capture significant market share in the coming years.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-10-05 | Kunkel Joachim () | Buy | 633.00 | 0.00 | Common Stock |
| 2026-10-05 | Munce Claudia F. () | Buy | 605.00 | 0.00 | Common Stock |
| 2026-10-05 | Alpern Paul L (VP and General Counsel) | Sell | 6,003.00 | 24.24 | Common Stock |
| 2026-10-05 | JANAC K CHARLES (President and CEO) | Sell | 11,452.00 | 24.27 | Common Stock |
| N/A | JANAC K CHARLES (President and CEO) | Holding | 8,129,071.00 | N/A | Common Stock |
| N/A | JANAC K CHARLES (President and CEO) | Holding | 56,252.00 | N/A | Common Stock |
| 2026-10-02 | Moll Laurent R (Chief Operating Officer) | Sell | 887.00 | 24.64 | Common Stock |
| 2026-10-02 | Moll Laurent R (Chief Operating Officer) | Sell | 1,931.00 | 24.64 | Common Stock |
| 2026-10-02 | Moll Laurent R (Chief Operating Officer) | Sell | 1,889.00 | 24.64 | Common Stock |
| 2026-10-02 | Moll Laurent R (Chief Operating Officer) | Sell | 893.00 | 24.64 | Common Stock |
| 2026-10-05 | Moll Laurent R (Chief Operating Officer) | Sell | 12,219.00 | 24.29 | Common Stock |




